) and Theranos, Inc. have entered into a long-term partnership,
whereby the new lab testing service of the latter will be
available throughout the wide network of Walgreens'
According to the agreement, services from Theranos Wellness
Centres will be offered inside Walgreens stores. The first such
flagship Theranos Wellness Center is due to be set up at 300
University Ave. in Palo Alto, CA -- the heart of Silicon Valley.
Going forward, the companies intend to introduce this service at
all Walgreens outlets located across the country.
The deal envisages Theranos' vision of introducing, for the first
time, CLIA-certified laboratory services capable of running its
tests on micro-samples. The test promises to eliminate the need
for intimidating needles or multiple blood vials required in
conventional diagnostic methods.
A tiny finger stick or a micro-sample from an intravenous draw
will initiate the diagnostic process with greater ease and
accuracy. All kinds of samples - blood, urine or fluids - can be
taken through this lab testing service, thus catering to
different diagnostic needs.
GNC HOLDINGS (GNC): Free Stock Analysis
HERBALIFE LTD (HLF): Free Stock Analysis
SUPERNUS PHARMA (SUPN): Free Stock Analysis
WALGREEN CO (WAG): Free Stock Analysis Report
To read this article on Zacks.com click here.
Theranos is keen to change the entire lab testing experience for
patients into a more user-friendly and convenient one. Most of
Theranos tests are also low priced, being almost 50% of Medicare
reimbursement rates or less. Moreover, they are also reimbursed
by majority of the insurance carriers, like Medicare and
Theranos' excellence in laboratory infrastructure cannot be
questioned as the wholly automated system guarantees minimal
human errors with high quality results. Moreover, delivery of
test results is promised to physicians within a few hours, which
helps the physicians to initiate the treatment process as early
as possible. The high-tech solutions of Theranos offer clinicians
a new standard of care across all specialties and treatment
areas, including oncology, pediatric and geriatric patients,
which involve frequent blood draws.
The extensive network of Walgreens retail pharmacy chain will
enable Theranos to make their services both accessible and
credible for consumers. Physicians will also be benefitted as
they would be able to render prompt and accurate treatment
Walgreens aims to radically transform its community pharmacy
facility by providing a full range of high-end services at the
right time and at convenient locations. With 8100 neighbourhood
pharmacies and still counting, it stands as the perfect choice
for Theranos to expand their diagnostic services on a
Currently, WAG carries a Zacks Rank #3 (Hold). Other medical
stocks that are worth a look include
Supernus Pharmaceuticals, Inc.
), carrying a Zacks Rank #1 (Strong Buy), and
GNC Holdings Inc.
), each of which carries a Zacks Rank #2 (Buy).